Samir Bhattacharyya

ORCID: 0009-0008-2534-0702
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Sexual function and dysfunction studies
  • Pelvic floor disorders treatments
  • Urinary Bladder and Prostate Research
  • Prostate Cancer Diagnosis and Treatment
  • Kidney Stones and Urolithiasis Treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Total Knee Arthroplasty Outcomes
  • Orthopaedic implants and arthroplasty
  • Sexuality, Behavior, and Technology
  • Dialysis and Renal Disease Management
  • Osteoarthritis Treatment and Mechanisms
  • Hormonal and reproductive studies
  • Pediatric Urology and Nephrology Studies
  • Ureteral procedures and complications
  • Periodontal Regeneration and Treatments
  • Advanced Radiotherapy Techniques
  • Urinary Tract Infections Management
  • Inflammatory mediators and NSAID effects
  • LGBTQ Health, Identity, and Policy
  • Orthopedic Infections and Treatments
  • Foreign Body Medical Cases
  • Healthcare cost, quality, practices
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Reproductive Health and Contraception
  • Healthcare Policy and Management

Boston Scientific (United States)
2020-2025

Foster-Miller (United States)
2022

Boston Scientific (Netherlands)
2021

Ipsen (France)
2021

Janssen (Belgium)
2021

Augmenix (United States)
2021

AstraZeneca (Singapore)
2021

Woodward (United States)
2021

AstraZeneca (Brazil)
2021

Elekta (Switzerland)
2021

To evaluate the prevalence of nocturia and its effects, with without concomitant overactive bladder (OAB, i.e. urgency, frequency, urge incontinence nocturia), on health-related quality life (HRQoL) sleep.A national survey was conducted in USA to assess OAB nocturia. A nested case-control study among respondents symptoms age- gender-matched controls, participants completing a series questionnaires HRQoL (OAB-q, Short Form-36, Medical Outcomes Study (MOS) sleep scale). Descriptive analyses,...

10.1111/j.1464-410x.2003.04527.x article EN BJU International 2003-11-24

SUMMARYThe prevalence of osteoporosis increases with age. The over-50-year-old population is expected to grow by 10% and 25% 2010 2020, respectively. There are already 3 million UK residents the public health impact will increase substantially over next 20 years. A Markov model natural history was used predict fracture numbers corresponding costs for aged 50-99 from 2000 2020. predicts 190,000 osteoporosis-related fractures at a cost £1.8 billion in 2000. By annual osteoporotic 21% 230,000...

10.3111/200104051062 article EN Journal of Medical Economics 2001-01-01

To determine the efficacy of platelet-rich plasma (PRP) injections for symptomatic tendinopathy.Systematic review randomised, injection-controlled trials with meta-analysis.Systematic searches MEDLINE and EMBASE, supplemented by manual searches.Randomised controlled 3 months minimum follow-up that evaluated pain reduction PRP versus control (saline, local anaesthetic, corticosteroid) in patients tendinopathy.A total 16 randomised (18 groups) were included. Median sample size was 35 patients,...

10.1136/bmjsem-2017-000237 article EN cc-by-nc BMJ Open Sport & Exercise Medicine 2017-11-01

Purpose: To determine the prevalence, incidence, and determinants of kidney stones among adults in United States. Materials Methods: This cross-sectional observational study evaluated lifetime prevalence 12-month incidence stone passage from 2017 to 2020 National Health Nutrition Examination Survey. Survey statistical methods were used estimate association patient characteristics with these outcomes using logistic regression. Results: The analysis included 9208 participants data 9193 data....

10.1097/ju9.0000000000000107 article EN cc-by-nc-nd JU Open Plus 2024-01-01

This study assessed the association between hyaluronic acid (HA) injections and time-to-total knee replacement (TKR) surgery for patients with osteoarthritis (OA). Patients 18 to 64 years of age who had TKR January 1, 2006 December 31, 2011 were identified from MarketScan Commercial claims database. All 6 or more continuous enrollment prior surgery. There two cohorts (1) HA (2) did not have Time-to-TKR was defined as total days date diagnosis OA on patient's first visit an orthopedic surgeon...

10.1055/s-0035-1568992 article EN The Journal of Knee Surgery 2015-12-07

Patient out-of-pocket (OOP) cost represents an access barrier to erectile dysfunction (ED) treatment. We determined OOP for men with ED covered by Fee-for-Service Medicare. Coverage policies were obtained from the Medicare Database treatments recommended 2018 American Urological Association (AUA) guidelines. was retrieved 2023 Centers & Medicaid Services Final Rule. without coverage extracted GoodRx® or literature and inflated 2022 dollars. Annual prescription costs calculated using...

10.1038/s41443-024-00903-9 article EN cc-by International Journal of Impotence Research 2024-06-26

365 Background: Rectal spacers have been shown to reduce side effects of prostate radiotherapy (RT) in cancer (PCa) patients clinical studies. While rectal spacing may help preserve sexual function after RT, this association has not explored large-scale real-world data. This study evaluated the between spacer use and prevalence erectile dysfunction diagnosis among PCa receiving RT at U.S. county level. Methods: utilized Medicare 5% 100% Standard Analytic Files analyze county-level The...

10.1200/jco.2025.43.5_suppl.365 article EN Journal of Clinical Oncology 2025-02-10

Importance The polyethylene glycol-based hydrogel spacer (PHS) system temporarily separates the rectum from prostate in patients undergoing radiotherapy (RT) for cancer (PCa). Objective To compare incidence of bowel disorders and related procedures receiving RT with without PHS. Design, Setting, Participants This retrospective cohort study used 4 datasets: Medicare 5% Standard Analytic Files, 100% Merative MarketScan Commercial Database, Premier Healthcare Database. included adult PCa 2015...

10.1001/jamanetworkopen.2025.0491 article EN cc-by-nc-nd JAMA Network Open 2025-03-11

Background Therapeutic success of platelet-rich plasma (PRP) may vary based on the composition and preparation method. The objective this study was to evaluate cellular components platelet concentrates produced by a leucocyte-rich (LR-PRP) leucocyte-poor PRP systems (LP-PRP). Methods Parameters evaluated included recovery, concentration, red blood cell (RBC) white (WBC) composition, growth factor release stimulation human tendon proliferation in vitro. Results Platelet recoveries were 52%...

10.1136/bmjsem-2015-000071 article EN cc-by-nc BMJ Open Sport & Exercise Medicine 2016-03-01
Coming Soon ...